SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-24-004670
Filing Date
2024-08-12
Accepted
2024-08-12 08:00:41
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cmpx20240630_10q.htm   iXBRL 10-Q 906315
2 EXHIBIT 31.1 ex_706317.htm EX-31.1 13801
3 EXHIBIT 32.1 ex_706318.htm EX-32.1 6018
  Complete submission text file 0001171843-24-004670.txt   4555780

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20240630.xsd EX-101.SCH 40652
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpx-20240630_def.xml EX-101.DEF 267690
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20240630_lab.xml EX-101.LAB 246520
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20240630_pre.xml EX-101.PRE 299474
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpx-20240630_cal.xml EX-101.CAL 32931
63 EXTRACTED XBRL INSTANCE DOCUMENT cmpx20240630_10q_htm.xml XML 717415
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 241194781
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)